16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Sept. 9<br />
Sunday<br />
PM<br />
SCIENTIFIC SESSION<br />
SATELLITE SYMPOSIUM<br />
Sept. 9<br />
Sunday, September 9<br />
3:30-6:00 PM<br />
<strong>Meeting</strong> Room 616<br />
Sunday, September 9<br />
4:00-6:00 PM<br />
Ballroom 6C<br />
Sunday<br />
PM<br />
sunday<br />
Joint Session with ICCAC-VAD<br />
Moderators: Michael G. Petty, Minneapolis, MN<br />
Timothy B. Icenogle, Spokane, WA<br />
Chair: Leslie A. Saxon, Los Angeles, CA<br />
4:00 Welcome and Introduction<br />
Leslie A. Saxon, Los Angeles, CA<br />
The Impact <strong>of</strong> New Rhythm Device Technology on<br />
Patient Management Options<br />
Sunday<br />
Obtaining Consent: What Do You Tell Patients and Families<br />
Considering VAD Therapy?<br />
3:30 Setting Expectations: Education or Sales?<br />
Jeffrey J. Teuteberg, Pittsburgh, PA<br />
3:40 What if They Say No? Palliative Care Options<br />
Kristen G. Schaefer, Boston MA<br />
3:50 Caregiver Commitment: What Does Support Entail?<br />
AnneMarie Kaan, Vancouver, BC, Canada<br />
4:00 Discussion<br />
How High is The Bar For a “Good” Destination?<br />
4:10 What Predicted Survival is a “Good” Destination?<br />
Michael M. Givertz, Boston, MA<br />
4:05* The Incidence and Management <strong>of</strong> Inappropriate Shocks<br />
in Patients with <strong>Heart</strong> <strong>Failure</strong>s<br />
Michael R. Gold, Charleston, SC<br />
4:30* The Role <strong>of</strong> ICDs With and Without Leads in the<br />
Management <strong>of</strong> Patients with <strong>Heart</strong> <strong>Failure</strong><br />
Martin C. Burke, Chicago, IL<br />
4:55* A New Look at Device Diagnostics: What Should We Be<br />
Measuring?<br />
John P. Boehmer, Hershey, PA<br />
5:15* Could an ICD with Monitoring Features Prevent <strong>Heart</strong><br />
<strong>Failure</strong> Progression?<br />
Lynne W. Stevenson, Boston, MA<br />
4:20 What Level <strong>of</strong> Adverse Events is Acceptable?<br />
Robert L. Kormos, Pittsburgh, PA<br />
4:30 What Quality <strong>of</strong> Life makes a “Good” Destination?<br />
Suzanne Chillcott, San Diego, CA<br />
5:20 Clinical Implications: Approaches to Managing Patients<br />
with <strong>Heart</strong> <strong>Failure</strong> and Hyponatremia<br />
Barry H. Greenberg, San Diego, CA<br />
5:35 Patient Management Case 1: Patient Monitoring<br />
John P. Boehmer, Hershey, PA<br />
5:45 Patient Management Case 2: A <strong>Heart</strong> <strong>Failure</strong> Patient<br />
with Arrhythmia<br />
Leslie A. Saxon, Los Angeles, CA<br />
5:55 Final Comments and Discussion<br />
Faculty<br />
*Includes 5 minute question-and-answer<br />
4:40 Discussion<br />
Going Home: Support Outside the Hospital<br />
4:50 The VAD Community on Line: MyAD.com<br />
Steven W. Boyce, Washington, DC<br />
5:00 What is the Social Support Necessary For VAD Success?<br />
Michael G. Petty, Minneapolis, MN<br />
5:10 Discussion<br />
Programmatic Issues<br />
5:20 Adjusting Anticoagulation: Striking a Balance to Prevent<br />
Embolic Stroke And GI Bleeds<br />
Ranjit John, Minneapolis, MN<br />
Learning Objectives:<br />
1. Manage and avoid complications with inappropriate<br />
ICD shocks<br />
2. Explain the rationale for the use <strong>of</strong> subcutaneous ICD<br />
devices in suitable patients with severe heart failure<br />
3. Identify the benefits and pitfalls <strong>of</strong> remote physiologic<br />
monitoring with implantable devices<br />
4. Outline a strategy for the use <strong>of</strong> remote monitoring in<br />
patients with heart failure<br />
5. Choose appropriate devices for patients with heart<br />
failure at high risk for arrhythmic death<br />
5:30 What is a Sustainable Ratio <strong>of</strong> VAD Coordinators to<br />
Patients: In New and Established Programs<br />
Dawn M. Christensen, Hershey, PA<br />
Supported by an educational grant from Boston <strong>Scientific</strong><br />
Corporation, Inc.<br />
5:40 Discussion<br />
Learning Objective: Identify factors important to the success <strong>of</strong><br />
VAD therapy and how to manage them.<br />
This symposium is not part <strong>of</strong> the scientific<br />
program as planned by the HFSA <strong>Scientific</strong><br />
Program Committee.<br />
6:00 Opening Reception<br />
2012 HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Exhibit Hall 4B<br />
6:00 Opening Reception<br />
2012 HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Exhibit Hall 4B<br />
36 37
Change language